Table 1.
Compound Name | Control * | EMPA | p-Value ‡ | EMPA-to-Control Ratio |
---|---|---|---|---|
Carbamoyl phosphate | 1.38 ± 0.53 | 0.65 ± 0.14 | 0.23 | 0.47 |
Spermine | 1.38 ± 0.18 | 0.66 ± 0.07 | 0.0036 | 0.48 |
2-Isopropylmalic acid | 1.27 ± 0.12 | 0.68 ± 0.08 | 0.0021 | 0.54 |
Succinate | 1.30 ± 0.31 | 0.72 ± 0.07 | 0.11 | 0.56 |
Trans-Aconitate | 1.23 ± 0.27 | 0.71 ± 0.12 | 0.12 | 0.58 |
Xanthurenic acid | 1.29 ± 0.14 | 0.77 ± 0.06 | 0.0057 | 0.59 |
Phenyllactic acid | 1.10 ± 0.43 | 0.68 ± 0.08 | 0.39 | 0.62 |
2-Deoxyguanosine 5-monophosphate | 1.33 ± 0.17 | 0.84 ± 0.11 | 0.036 | 0.63 |
4-Pyridoxate | 1.27 ± 0.17 | 0.76 ± 0.10 | 0.022 | 0.63 |
Putrescine | 1.22 ± 0.14 | 0.77 ± 0.08 | 0.018 | 0.64 |
Spermidine | 1.24 ± 0.07 | 0.84 ± 0.06 | 0.00078 | 0.67 |
† QC-RLSC normalized peak intensities, * mean ± sem (n = 8-control; 7-empagliflozin); ‡ unpaired t-test.